CASI Pharmaceuticals Inc (CASI)
2.34
-0.08
(-3.31%)
USD |
NASDAQ |
Apr 29, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
CASI Pharmaceuticals Enterprise Value: 19.49M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 19.49M |
| April 26, 2024 | 20.56M |
| April 25, 2024 | 18.95M |
| April 24, 2024 | 20.83M |
| April 23, 2024 | 21.76M |
| April 22, 2024 | 20.69M |
| April 19, 2024 | 18.28M |
| April 18, 2024 | 18.15M |
| April 17, 2024 | 18.15M |
| April 16, 2024 | 19.49M |
| April 15, 2024 | 21.63M |
| April 12, 2024 | 22.97M |
| April 11, 2024 | 23.64M |
| April 10, 2024 | 27.79M |
| April 09, 2024 | 30.07M |
| April 08, 2024 | 29.80M |
| April 05, 2024 | 31.01M |
| April 04, 2024 | 32.48M |
| April 03, 2024 | 31.95M |
| April 02, 2024 | 35.16M |
| April 01, 2024 | 37.18M |
| March 28, 2024 | 36.51M |
| March 27, 2024 | 28.33M |
| March 26, 2024 | 28.33M |
| March 25, 2024 | 28.20M |
| Date | Value |
|---|---|
| March 22, 2024 | 29.13M |
| March 21, 2024 | 29.00M |
| March 20, 2024 | 29.73M |
| March 19, 2024 | 29.33M |
| March 18, 2024 | 28.66M |
| March 15, 2024 | 30.67M |
| March 14, 2024 | 34.82M |
| March 13, 2024 | 39.10M |
| March 12, 2024 | 42.98M |
| March 11, 2024 | 50.07M |
| March 08, 2024 | 53.28M |
| March 07, 2024 | 63.65M |
| March 06, 2024 | 66.92M |
| March 05, 2024 | 63.85M |
| March 04, 2024 | 56.15M |
| March 01, 2024 | 61.84M |
| February 29, 2024 | 62.91M |
| February 28, 2024 | 64.25M |
| February 27, 2024 | 61.44M |
| February 26, 2024 | 60.90M |
| February 23, 2024 | 62.38M |
| February 22, 2024 | 61.44M |
| February 21, 2024 | 62.38M |
| February 20, 2024 | 63.04M |
| February 16, 2024 | 65.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.265M
Minimum
Mar 20 2023
406.87M
Maximum
Jan 26 2021
127.16M
Average
113.93M
Median
Jul 30 2021
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.055M |
| Revenue (Quarterly) | 6.874M |
| Total Expenses (Quarterly) | 10.33M |
| EPS Diluted (Quarterly) | -0.46 |
| Gross Profit Margin (Quarterly) | 59.05% |
| Profit Margin (Quarterly) | -88.09% |
| Earnings Yield | -86.75% |
| Normalized Earnings Yield | -79.17 |